Skip to main content
Fig. 3 | Malaria Journal

Fig. 3

From: A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria

Fig. 3

PCR-adjusted ACPR at Day 28 by age (African patients) and by region (PP Sets). All doses of artefenomel and ferroquine are expressed as adult-equivalent doses. n: number of patients in each category achieving ACPR. r: total number of patients in the relevant analysis set with a defined response of Cure or Failure (i.e. patients evaluable for the outcome considered). 95% CI L: lower limit of 95% confidence interval; 95% CI U: upper limit of 95% confidence interval

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us